The estimated Net Worth of John Bencich is at least $1.2 millió dollars as of 19 April 2024. Mr Bencich owns over 25,000 units of Achieve Life Sciences stock worth over $435,379 and over the last 7 years he sold ACHV stock worth over $0. In addition, he makes $767,250 as CEO & Director at Achieve Life Sciences.
Mr has made over 14 trades of the Achieve Life Sciences stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of ACHV stock worth $107,000 on 19 April 2024.
The largest trade he's ever made was exercising 25,000 units of Achieve Life Sciences stock on 19 April 2024 worth over $107,000. On average, Mr trades about 4,286 units every 93 days since 2017. As of 19 April 2024 he still owns at least 101,724 units of Achieve Life Sciences stock.
You can see the complete history of Mr Bencich stock trades at the bottom of the page.
John A. Bencich M.B.A. is the CEO & Director at Achieve Life Sciences.
As the CEO & Director of Achieve Life Sciences, the total compensation of Mr A at Achieve Life Sciences is $767,250. There are 1 executives at Achieve Life Sciences getting paid more, with Richard Stewart having the highest compensation of $796,644.
Mr A is 44, he's been the CEO & Director of Achieve Life Sciences since . There are 12 older and 3 younger executives at Achieve Life Sciences. The oldest executive at Achieve Life Sciences Inc. is Donald Joseph, 66, who is the Independent Director.
John's mailing address filed with the SEC is 22722 29TH DR SE, SUITE 100, BOTHELL, WA, 98021.
Over the last 7 years, insiders at Achieve Life Sciences have traded over $972,224 worth of Achieve Life Sciences stock and bought 70,500 units worth $224,475 . The most active insiders traders include Capital, Llc Armistice Capi..., Vaughn B Himes és Jay M Moyes. On average, Achieve Life Sciences executives and independent directors trade stock every 65 days with the average trade being worth of $63,759. The most recent stock trade was executed by Jerry Wan on 19 April 2024, trading 5,625 units of ACHV stock currently worth $24,075.
achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
Achieve Life Sciences executives and other stock owners filed with the SEC include: